NDC 50419-403
Safyral
Drospirenone/ethinyl Estradiol/levomefolate Calcium And Levomefolate Calcium
Safyral is a Kit in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is .
| Product ID | 50419-403_1f9b9239-b41b-4580-9775-9e93a4f73e1c |
| NDC | 50419-403 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Safyral |
| Generic Name | Drospirenone/ethinyl Estradiol/levomefolate Calcium And Levomefolate Calcium |
| Dosage Form | Kit |
| Marketing Start Date | 2012-02-13 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022574 |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 50419-403-00
90 BLISTER PACK in 1 PACKAGE (50419-403-00) > 1 KIT in 1 BLISTER PACK
| Marketing Start Date | 2012-02-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50419-403-75 [50419040375]
Safyral KIT
| Marketing Category | NDA |
| Application Number | NDA022574 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-02-13 |
NDC 50419-403-70 [50419040370]
Safyral KIT
| Marketing Category | NDA |
| Application Number | NDA022574 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-02-13 |
NDC 50419-403-03 [50419040303]
Safyral KIT
| Marketing Category | NDA |
| Application Number | NDA022574 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-02-13 |
NDC 50419-403-71 [50419040371]
Safyral KIT
| Marketing Category | NDA |
| Application Number | NDA022574 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-12-22 |
NDC 50419-403-01 [50419040301]
Safyral KIT
| Marketing Category | NDA |
| Application Number | NDA022574 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-12-22 |
NDC 50419-403-00 [50419040300]
Safyral KIT
| Marketing Category | NDA |
| Application Number | NDA022574 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-02-13 |
Drug Details
OpenFDA Data
| SPL SET ID: | 97563516-306a-4e17-9690-edbda49ecd83 |
| Manufacturer | |
| RxNorm Concept Unique ID - RxCUI |
Medicade Reported Pricing
50419040303 SAFYRAL TABLET
Pricing Unit: EA | Drug Type:
NDC Crossover Matching brand name "Safyral" or generic name "Drospirenone/ethinyl Estradiol/levomefolate Calcium And Levomefolate Calcium"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50419-403 | Safyral | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium |
| 50419-407 | Beyaz | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium |
| 0781-4075 | Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium |
| 0781-4103 | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium |
Trademark Results [Safyral]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SAFYRAL 85040002 3991077 Live/Registered |
Bayer Aktiengesellschaft 2010-05-17 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.